External Contributer Articles of Labiotech.eu

About

Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.

Articles by External Contributor

News and Trends 11 Jan 2023

Five key trends shaping life sciences in 2023

By Kevin Wayer, president – government, education, infrastructure and life sciences industries, JLL, and Travis McCready, head of life sciences, industries Americas, JLL After an unprecedented period of growth during the pandemic, life sciences activity normalized in 2022. The life sciences industry has not been immune to the macroeconomic challenges plaguing the global economy, but […]

January 11, 2023 - 5 minutesmins - By External Contributor

News and Trends 11 Jan 2023

2023 life sciences industry trends: adopting a digital-first mindset

By Pat Jenakanandhini, chief product officer, ArisGlobal With the new year here, life science organizations have reached technology crossroads in choosing whether to embrace a digital-first mindset and adopt innovative digital technologies or hold fast to legacy processes. Digital transformation has driven newer technologies designed to improve efficiency, patient care and workflows. Those who choose […]

January 11, 2023 - 4 minutesmins - By External Contributor

News and Trends 11 Jan 2023

Clinical trends for 2023

By Richard Staines, account director, Optimum Strategic Communications Few would deny that the decade has had a turbulent start, but after the tragedies of the COVID-19 pandemic and the Ukraine war, there’s hope that 2023 will see a new wave of clinical research. Exciting new technologies such as gene editing, gene therapy and a next […]

January 11, 2023 - 8 minutesmins - By External Contributor

News and Trends 11 Jan 2023

2023: A pivotal time for medicine as it enters a new ‘personalized’ era

By Hakim Yadi, co-founder and CEO of Closed Loop Medicine The traditional healthcare delivery model is designed to cater to the masses, rather than the individual. Administering treatments based on the overall safety and efficacy demonstrated in large-scale clinical trials, and not taking into consideration individual responses to such treatments, is resulting in poorer outcomes […]

January 11, 2023 - 5 minutesmins - By External Contributor

News and Trends 11 Jan 2023

We DUB this target ‘druggable’

By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich source for drug discovery. Recent years have seen the clinical validation of proteolysis-targeting chimeras (PROTACs) unlock the ability to drug the undruggable, by exploiting E3 ligases to mediate targeted protein degradation (TPD), paving the way to tackle exciting new drug […]

January 11, 2023 - 5 minutesmins - By External Contributor

News and Trends 14 Dec 2022

How biotech startups can innovate through embracing applied research

By Kathleen Lee, director of the Arizona WearTech Applied Research Center Innovation is about breaking new ground and forging new pathways to confront societal issues and solve problems. Many startup companies, especially in the biotech industries, are working towards finding solutions to some of these most complex problems. All solutions start as mere ideas, and […]

December 14, 2022 - 5 minutesmins - By External Contributor

News and Trends 14 Dec 2022

Navigating running a startup as a Gen Z female founder

By: Alina Su, CEO and founder of NovaXS Biotech Corp The next generation of biotech founders are facing new challenges. Despite the access to a world of opportunity on the internet, pursuing your dreams as a Generation Z female biotech founder is not easy. Gen Z has the unpopular stereotype that they are lazy and […]

December 14, 2022 - 7 minutesmins - By External Contributor

News and Trends 14 Dec 2022

The crucial importance of project management for healthcare startups

By Clémentine Duflot, consultant at HC NEXT In an effervescent healthcare innovation field, where risk-assessment and time-to-market are key to break through and survive, speeding and derisking drug and medical device developments to ensure each innovation becomes a product to benefit patients is essential. A drug or medical device development project requires a high level […]

December 14, 2022 - 3 minutesmins - By External Contributor

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

Despite the onset of the genomics era, rare disease diagnosis remains a challenge. Nostos Genomics’ co-founder, Rocío Acuña Hidalgo, and chief operating officer, Ansgar Lange, shed light on how artificial intelligence (AI) could fill in the gaps. It is estimated that 300 million people worldwide are affected by rare diseases and around 80% of these […]

December 12, 2022 - 6 minutesmins - By External Contributor

News and Trends 14 Nov 2022

A new treatment for tackling epidermolysis bullosa

By Jordi Casals, president, EMEA, Amryt Pharma Epidermolysis bullosa (EB), sometimes described as “the worst disease you’ve never heard of,” is a group of rare and distressing inherited skin disorders primarily diagnosed in young children. The genetic mutations that cause EB can result in the skin being extremely fragile. Any physical contact with the skin […]

November 14, 2022 - 3 minutesmins - By External Contributor

News and Trends 14 Nov 2022

RSV cases are rising fast in children. Early detection can help.

By Shawn Gaskell, MilliporeSigma RSV-related hospitalizations for 2022 have already surged to unusually high numbers, surpassing cumulative cases typically reported in late December each year, and we’re not even one month into the season. While no age group is immune to RSV— respiratory syncytial virus— and the trouble it can cause, young children are being […]

November 14, 2022 - 5 minutesmins - By External Contributor

News and Trends 14 Nov 2022

A biotech boom manifesting real results in rare pediatric diseases

By Bob Coughlin, managing director, life sciences, JLL For the last two years, the pandemic has resulted in the explosive growth in life sciences. The world watched in awe and anticipation as biotech successfully raced to develop vaccines, therapeutics and diagnostics for Covid-19. It has been a good moment for an industry that deserves such […]

November 14, 2022 - 5 minutesmins - By External Contributor

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

External Contributor

About

Articles by External Contributor

Five key trends shaping life sciences in 2023

2023 life sciences industry trends: adopting a digital-first mindset

Clinical trends for 2023

2023: A pivotal time for medicine as it enters a new ‘personalized’ era

We DUB this target ‘druggable’

How biotech startups can innovate through embracing applied research

Navigating running a startup as a Gen Z female founder

The crucial importance of project management for healthcare startups

Artificial intelligence: a new era in rare genetic disease diagnosis

A new treatment for tackling epidermolysis bullosa

RSV cases are rising fast in children. Early detection can help.

A biotech boom manifesting real results in rare pediatric diseases

Subscribe to our newsletter to get the latest biotech news!